FTFT vs REGN · P/E 0.0, rev $2.2M vs P/E 14, rev $14.34B
Future Fintech Group Inc (FTFT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Future Fintech Group Inc (FTFT) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FTFT revenue for 2024-12-31 was $2.2M. Net income was -$33.2M. Revenue was down 90.1% from 2023-12-31 to 2024-12-31. FTFT currently screens at market cap $6.3M and trailing P/E 0.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FTFT currently screens at market cap $6.3M and trailing P/E 0.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FTFT and REGN stock pages for the full models.
Not investment advice.